Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin, Docetaxel and ADT for Rising PSA After Local Therapy
NCT00658697Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jun 2008
- Primary completion
- Sep 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in prostate cancer (PCa), sponsored by Dana-Farber Cancer Institute. Started Jun 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00658697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00658697.